Gürcan Tunalı on Muck Rack

Gürcan Tunalı

As seen in: The Journal of Clinical Investigation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gürcan

Contact Gürcan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy

|
By Divya Bharathi Nagarajan, Gürcan Tunalı, Marta Rúbies Bedós, Patrik Fridh
| The Journal of Clinical Investigation
ResearchIn-Press PreviewImmunologyOncology Open Access | 10.1172/JCI161084 J Clin Invest. https://doi.org/10.1172/JCI161084. Copyright © 2023, Tunalı et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. View PDF Abstract Inflammatory mediators released by cancer cells promote the induction of immune suppression and tolerance in myeloid cells.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified